Skip to main content
Technical Notice

TRACE Allocations

February 05, 2026

Beginning Monday, June 8, 2026, as described in Regulatory Notice 25-17, FINRA will introduce a new “Allocations” field across all TRACE products. This new field permits a firm that is both a broker-dealer and an investment adviser to report allocations of specified orders to managed customer accounts in a streamlined, aggregated manner.

Project TimelineDate
NTF*March 23, 2026
UAT 1May 9, 2026
UAT 2May 16, 2026
ProductionJune 8, 2026

FINRA has updated the below documentation to reflect the change. Please note: The FIX changes will be available in both the current legacy and Native FIX environments.

TRACE FIX SpecificationEffective June 8, 2026
Corporates and Agencies (Legacy)Version 1.6
Corporates and Agencies (Native FIX)Version 2.1
Securitized Products (Legacy)Version 1.9
Securitized Products (Native FIX)Version 2.1
Treasury Securities (Legacy)Version 1.6
Treasury Securities (Native FIX)Version 2.1
Web User GuidesEffective June 8, 2026
Corporates and Agencies Version 6.3
Securitized ProductsVersion 6.3
Treasury SecuritiesVersion 3.3
Dissemination  Effective June 8, 2026
TRACE BTDS SpecificationBTDS MOLD/UDP v5.1
TRACE BTDS 144a SpecificationBTDS-144A MOLD/UDP v3.1
TRACE ATDS SpecificationATDS MOLD/UDP v4.1
TRACE SPDS SpecificationSPDS MOLD/UDP v3.1
TRACE SPDS 144a SpecificationSPDS-144A MOLD/UDP v2.1

The FINRA ADDS User Guide will be updated at a future date.

*TRACE clients may test free of charge in NTF for 30 calendar days. All users must notify [email protected] at the commencement of their testing. Once a user informs the NASDAQ test team, the testing free period will continue uninterrupted for 30 calendar days. After the 30 - day period ends, normal NTF fees will apply for connecting and testing. Questions regarding NTF fees can be directed to Nasdaq Technical Services at (212) 231-5180.

Please contact FINRA Client & System Management  with technical questions regarding this notice. For all other questions related to this change, please refer to the contacts listed on the Regulatory Notice.